Deciphera Pharmaceuticals, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Deciphera Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Deciphera Pharmaceuticals, Inc. Return On Equity for the quarter ending March 31, 2024 was -52.4 %, a 12.6% decline year-over-year.
  • Deciphera Pharmaceuticals, Inc. annual Return On Equity for 2023 was -49.4 %, a 3.85% increase from 2022.
  • Deciphera Pharmaceuticals, Inc. annual Return On Equity for 2022 was -51.4 %, a 29.9% increase from 2021.
  • Deciphera Pharmaceuticals, Inc. annual Return On Equity for 2021 was -73.4 %, a 65.6% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -49.4 +1.98 +3.85% Jan 1, 2023 Dec 31, 2023
2022 -51.4 +22 +29.9% Jan 1, 2022 Dec 31, 2022
2021 -73.4 -29.1 -65.6% Jan 1, 2021 Dec 31, 2021
2020 -44.3 +3.29 +6.91% Jan 1, 2020 Dec 31, 2020
2019 -47.6 -10.8 -29.4% Jan 1, 2019 Dec 31, 2019
2018 -36.8 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.